Gastroparesis Drugs Market Size Share Growth Opportunities and Forecast 2022

Gastroparesis Drugs Market Size, Competitive Landscape and Market Forecast - 2029

<h2>Global Gastroparesis Drugs Market is segmented&nbsp;By Drug Type (Prokinetic Agents, Antiemetic Agents, Botulinum Toxin Injections),&nbsp;By Disease Type (Diabetic Gastroparesis, Idiopathic Gastroparesis, Postsurgical Gastroparesis),&nbsp;By Distribution Channel (Hospital and Clinics, Retail Pharmacies, Online Pharmacies),&nbsp;and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2022-2029</h2>

&nbsp;

<h2>Market Overview</h2>

<blockquote>
The Global &quot;Gastroparesis Drugs Market&quot;&nbsp;is expected to grow at a <a href="https://www.datamintelligence.com/download-sample/gastroparesis-drugs-market">CAGR</a>&nbsp;during the forecasting period (2022-2029).
</blockquote>

<h2>Trending Topics</h2>

<a href="https://www.datamintelligence.com/download-sample/osteoporosis-market">Osteoporosis Drugs Market</a>

<a href="https://www.datamintelligence.com/download-sample/schizophrenia-drugs-market">Schizophrenia Drugs Market</a>

<a href="https://www.datamintelligence.com/download-sample/schistosomiasis-drugs-market">Schistosomiasis Drugs Market</a>

<h2>&nbsp;</h2>

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">Table of Contents</h2>

<ol>
	<li>Methodology and Scope

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>Market Definition and Overview</li>
	<li>Executive Summary
	<ol>
		<li>&nbsp;Market Snippet by Drug Type</li>
		<li>Market Snippet by Disease Type</li>
		<li>Market Snippet by Distribution Channel</li>
		<li>Market Snippet by Region</li>
		<li>DataM CLO Scenario</li>
	</ol>
	</li>
	<li>Market Dynamics
	<ol>
		<li>Market Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Rise in number of surgeries</li>
				<li>Rise in diabetic population</li>
				<li>Increase in geriatric population</li>
			</ol>
			</li>
			<li>Restraints
			<ol>
				<li>Side effects of drugs</li>
				<li>Stringent drug approval regulations</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>Industry Analysis&nbsp;
	<ol>
		<li>Porter&#39;s Five Forces Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Epidemiology</li>
	</ol>
	</li>
	<li>By Drug Type
	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type</li>
			<li>Market Attractiveness Index, By Drug Type</li>
		</ol>
		</li>
		<li>Prokinetic Agents
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Antiemetic Agents</li>
		<li>Botulinum Toxin Injections</li>
	</ol>
	</li>
	<li>By Disease Type
	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type</li>
			<li>Market Attractiveness Index, By Disease Type</li>
		</ol>
		</li>
		<li>Diabetic Gastroparesis
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026</li>
		</ol>
		</li>
		<li>&nbsp;Idiopathic Gastroparesis</li>
		<li>&nbsp;Postsurgical Gastroparesis</li>
	</ol>
	</li>
	<li>By Distribution Channel
	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Attractiveness Index, By Distribution Channel</li>
		</ol>
		</li>
		<li>Hospital and Clinics
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026</li>
		</ol>
		</li>
		<li>&nbsp;Retail Pharmacies</li>
		<li>&nbsp;Online Pharmacies</li>
	</ol>
	</li>
	<li>By Region
	<ol>
		<li>Introduction&nbsp;
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>U.K.</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Disease Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>Competitive Landscape
	<ol>
		<li>Competitive Scenario</li>
		<li>Competitor Gastroparesis Drugs Strategy Analysis</li>
		<li>Comparative Product Portfolio Analysis</li>
		<li>Market Positioning/Share Analysis</li>
		<li>Mergers and Acquisitions Analysis</li>
	</ol>
	</li>
	<li>Company Profiles
	<ol>
		<li>Allergan, Plc *
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Key Highlights</li>
			<li>Financial Overview</li>
		</ol>
		</li>
		<li>Abbott Laboratories</li>
		<li>AstraZeneca Plc</li>
		<li>Cadila Pharmaceuticals Ltd.</li>
		<li>ETX Pharma, Inc.</li>
		<li>Evoke Pharma</li>
		<li>GlaxoSmithKline Plc</li>
		<li>Neurogastrx, Inc.</li>
		<li>Valeant Pharmaceuticals International, Inc.</li>
		<li>Theravance Biopharma</li>
		<li>Johnson &amp; Johnson</li>
		<li>Teva Pharmaceutical Industries</li>
	</ol>
	</li>
	<li>Appendix</li>
	<li>About Us and Services</li>
	<li>Contact Us</li>
</ol>

<h2 style="background:#eeeeee; border:1px solid #cccccc; padding:5px 10px">List of Tables and Figures</h2>

List of Tables

Table 1 Global Gastroparesis Drugs Market Value, By Drug Type, 2021,2025&amp; 2029 ($ Million)

Table 2 Global Gastroparesis Drugs Market Value, By Disease Type, 2021,2025&amp; 2029 ($ Million)

Table 3 Global Gastroparesis Drugs Market Value, By Distribution Channel, 2021,2025&amp; 2029 ($ Million)

Table 4 Global Gastroparesis Drugs Market Value, By Region, 2021,2025&amp; 2029 ($ Million)

Table 5 Global Gastroparesis Drugs Market Value, By Drug Type, 2021,2025&amp; 2029 ($ Million)

Table 6 Global Gastroparesis Drugs Market Value, By Drug Type, 2017-2029 ($ Million)

Table 7 Global Gastroparesis Drugs Market Value, By Disease Type, 2021,2025&amp; 2029 ($ Million)

Table 8 Global Gastroparesis Drugs Market Value, By Disease Type, 2017-2029 ($ Million)

Table 9 Global Gastroparesis Drugs Market Value, By Distribution Channel, 2021,2025&amp; 2029 ($ Million)

Table 10 Global Gastroparesis Drugs Market Value, By Distribution Channel, 2017-2029 ($ Million)

Table 11 Global Gastroparesis Drugs Market Value, By Region, 2021,2025&amp; 2029 ($ Million)

Table 12 Global Gastroparesis Drugs Market Value, By Region, 2017-2029 ($ Million)

Table 13 North America Gastroparesis Drugs Market Value, By Drug Type, 2017-2029 ($ Million)

Table 14 North America Gastroparesis Drugs Market Value, By Disease Type, 2017-2029 ($ Million)

Table 15 North America Gastroparesis Drugs Market Value, By Distribution Channel, 2017-2029 ($ Million)

Table 16 North America Gastroparesis Drugs Market Value, By Country, 2017-2029 ($ Million)

Table 17 South America Gastroparesis Drugs Market Value, By Drug Type, 2017-2029 ($ Million)

Table 18 South America Gastroparesis Drugs Market Value, By Disease Type, 2017-2029 ($ Million)

Table 19 South America Gastroparesis Drugs Market Value, By Distribution Channel, 2017-2029 ($ Million)

Table 20 South America Gastroparesis Drugs Market Value, By Country, 2017-2029 ($ Million)

Table 21 Europe Gastroparesis Drugs Market Value, By Drug Type, 2017-2029 ($ Million)

Table 22 Europe Gastroparesis Drugs Market Value, By Disease Type, 2017-2029 ($ Million)

Table 23 Europe Gastroparesis Drugs Market Value, By Distribution Channel, 2017-2029 ($ Million)

Table 24 Europe Gastroparesis Drugs Market Value, By Country, 2017-2029 ($ Million)

Table 25 Asia-Pacific Gastroparesis Drugs Market Value, By Drug Type, 2017-2029 ($ Million)

Table 26 Asia-Pacific Gastroparesis Drugs Market Value, By Disease Type, 2017-2029 ($ Million)

Table 27 Asia-Pacific Gastroparesis Drugs Market Value, By Distribution Channel, 2017-2029 ($ Million)

Table 28 Asia-Pacific Gastroparesis Drugs Market Value, By Country, 2017-2029 ($ Million)

Table 29 Middle East &amp; Africa Gastroparesis Drugs Market Value, By Drug Type, 2017-2029 ($ Million)

Table 30 Middle East &amp; Africa Gastroparesis Drugs Market Value, By Disease Type, 2017-2029 ($ Million)

Table 31 Middle East &amp; Africa Gastroparesis Drugs Market Value, By Distribution Channel, 2017-2029 ($ Million)

Table 32 Allergan, Plc: Overview

Table 33 Allergan, Plc: Product Portfolio

Table 34 Allergan, Plc: Key Developments

Table 35 Abbott Laboratories: Overview

Table 36 Abbott Laboratories: Product Portfolio

Table 37 Abbott Laboratories: Key Developments

Table 38 AstraZeneca Plc: Overview

Table 39 AstraZeneca Plc: Product Portfolio

Table 40 AstraZeneca Plc: Key Developments

Table 41 Cadila Pharmaceuticals Ltd.: Overview

Table 42 Cadila Pharmaceuticals Ltd.: Product Portfolio

Table 43 Cadila Pharmaceuticals Ltd.: Key Developments

Table 44 ETX Pharma, Inc.: Overview

Table 45 ETX Pharma, Inc.: Product Portfolio

Table 46 ETX Pharma, Inc.: Key Developments

Table 47 Evoke Pharma: Overview

Table 48 Evoke Pharma: Product Portfolio

Table 49 Evoke Pharma: Key Developments

Table 50 GlaxoSmithKline Plc: Overview

Table 51 GlaxoSmithKline Plc: Product Portfolio

Table 52 GlaxoSmithKline Plc: Key Developments

Table 53 Neurogastrx, Inc.: Overview

Table 54 Neurogastrx, Inc.: Product Portfolio

Table 55 Neurogastrx, Inc.: Key Developments

Table 56 Valeant Pharmaceuticals International, Inc.: Overview

Table 57 Valeant Pharmaceuticals International, Inc.: Product Portfolio

Table 58 Valeant Pharmaceuticals International, Inc.: Key Developments

Table 59 Theravance Biopharma: Overview

Table 60 Theravance Biopharma: Product Portfolio

Table 61 Theravance Biopharma: Key Developments

&nbsp;

List of Figures

Figure 1 Global Gastroparesis Drugs Market Share, By Drug Type, 2018 &amp; 2029 (%)

Figure 2 Global Gastroparesis Drugs Market Share, By Disease Type, 2018 &amp; 2029 (%)

Figure 3 Global Gastroparesis Drugs Market Share, By Distribution Channel, 2018 &amp; 2029 (%)

Figure 4 Global Gastroparesis Drugs Market Share, By Region, 2018 &amp; 2029 (%)

Figure 5 Global Gastroparesis Drugs Market Value, 2017-2029 ($ Million)

Figure 6 Global Gastroparesis Drugs Market Y-o-Y Growth, By Drug Type, 2018-2029 (%)

Figure 7 Prokinetic Agents: Global Gastroparesis Drugs Market Value, 2017-2029 ($ Million)

Figure 8 Antiemetic Agents: Global Gastroparesis Drugs Market Value, 2017-2029 ($ Million)

Figure 9 Botulinum Toxin Injections: Global Gastroparesis Drugs Market Value, 2017-2029 ($ Million)

Figure 10 Global Gastroparesis Drugs Market Y-o-Y Growth, By Disease Type, 2018-2029 (%)

Figure 11 Diabetic Gastroparesis: Global Gastroparesis Drugs Market Value, 2017-2029 ($ Million)

Figure 12 Idiopathic Gastroparesis: Global Gastroparesis Drugs Market Value, 2017-2029 ($ Million)

Figure 13 Postsurgical Gastroparesis: Global Gastroparesis Drugs Market Value, 2017-2029 ($ Million)

Figure 14 Global Gastroparesis Drugs Market Y-o-Y Growth, By Distribution Channel, 2018-2029 (%)

Figure 15 Hospital and Clinics: Global Gastroparesis Drugs Market Value, 2017-2029 ($ Million)

Figure 16 Retail Pharmacies: Global Gastroparesis Drugs Market Value, 2017-2029 ($ Million)

Figure 17 Online Pharmacies: Global Gastroparesis Drugs Market Value, 2017-2029 ($ Million)

Figure 18 Global Gastroparesis Drugs Market Y-o-Y Growth, By Region, 2018-2029 (%)

Figure 19 North America Gastroparesis Drugs Market Value, 2017-2029 ($ Million)

Figure 20 North America Gastroparesis Drugs Market Share, By Drug Type, 2018 &amp; 2029 (%)

Figure 21 North America Gastroparesis Drugs Market Share, By Disease Type, 2018 &amp; 2029 (%)

Figure 22 North America Gastroparesis Drugs Market Share, By Distribution Channel, 2018 &amp; 2029 (%)

Figure 23 North America Gastroparesis Drugs Market Share, By Country, 2018 &amp; 2029 (%)

Figure 24 South America Gastroparesis Drugs Market Value, 2017-2029 ($ Million)

Figure 25 South America Gastroparesis Drugs Market Share, By Drug Type, 2018 &amp; 2029 (%)

Figure 26 South America Gastroparesis Drugs Market Share, By Disease Type, 2018 &amp; 2029 (%)

Figure 27 South America Gastroparesis Drugs Market Share, By Distribution Channel, 2018 &amp; 2029 (%)

Figure 28 South America Gastroparesis Drugs Market Share, By Country, 2018 &amp; 2029 (%)

Figure 29 Europe Gastroparesis Drugs Market Value, 2017-2029 ($ Million)

Figure 30 Europe Gastroparesis Drugs Market Share, By Drug Type, 2018 &amp; 2029 (%)

Figure 31 Europe Gastroparesis Drugs Market Share, By Disease Type, 2018 &amp; 2029 (%)

Figure 32 Europe Gastroparesis Drugs Market Share, By Distribution Channel, 2018 &amp; 2029 (%)

Figure 33 Europe Gastroparesis Drugs Market Share, By Country, 2018 &amp; 2029 (%)

Figure 34 Asia-Pacific Gastroparesis Drugs Market Value, 2017-2029 ($ Million)

Figure 35 Asia-Pacific Gastroparesis Drugs Market Share, By Drug Type, 2018 &amp; 2029 (%)

Figure 36 Asia-Pacific Gastroparesis Drugs Market Share, By Disease Type, 2018 &amp; 2029 (%)

Figure 37 Asia-Pacific Gastroparesis Drugs Market Share, By Distribution Channel, 2018 &amp; 2029 (%)

Figure 38 Asia-Pacific Gastroparesis Drugs Market Share, By Country, 2018 &amp; 2029 (%)

Figure 39 Middle East &amp; Africa Gastroparesis Drugs Market Value, 2017-2029 ($ Million)

Figure 40 Middle East &amp; Africa Gastroparesis Drugs Market Share, By Drug Type, 2018 &amp; 2029 (%)

Figure 41 Middle East &amp; Africa Gastroparesis Drugs Market Share, By Disease Type, 2018 &amp; 2029 (%)

Figure 42 Middle East &amp; Africa Gastroparesis Drugs Market Share, By Distribution Channel, 2018 &amp; 2029 (%)

Figure 43 Allergan, Plc: Financials

Figure 44 Abbott Laboratories: Financials

Figure 45 AstraZeneca Plc: Financials

Figure 46 Cadila Pharmaceuticals Ltd.: Financials

Figure 47 ETX Pharma, Inc.: Financials

Figure 48 Evoke Pharma: Financials

Figure 49 GlaxoSmithKline Plc: Financials

Figure 50 Neurogastrx, Inc.: Financials

Figure 51 Valeant Pharmaceuticals International, Inc.: Financials

Figure 52 Theravance Biopharma: Financials

Gastroparesis Drugs Market Size, Competitive Landscape and Market Forecast - 2029

Gastroparesis Drugs Market Size, Competitive Landscape and Market Forecast - 2029

Market Overview

Trending Topics

Buy This Report